Abbott Laboratories (ABT) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0028241000

Abbott Laboratories and its subsidiaries are a global company that specializes in discovering, developing, manufacturing, and selling a wide range of healthcare products. They operate in four main segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

The company offers a diverse portfolio of pharmaceuticals catering to various conditions such as pancreatic exocrine insufficiency, irritable bowel syndrome, gynecological disorders, and more. They also provide products like laboratory and transfusion medicine systems, including molecular diagnostics, point of care systems, and rapid diagnostics.

In addition to pharmaceuticals, Abbott Laboratories supplies pediatric and adult nutritional products, as well as devices for managing cardiovascular diseases, diabetes care products, and neuromodulation devices for chronic pain and movement disorders.

Founded in 1888 and headquartered in North Chicago, Illinois, Abbott Laboratories remains committed to improving global health. For more information, visit their website: https://www.abbott.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Abbott Laboratories (ABT) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Abbott Laboratories (ABT) - Stock Price & Dividends

ABT Stock Overview

Market Cap in USD 189,499m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1978-01-13

ABT Stock Ratings

Growth 5y 3.44
Fundamental 42.0
Dividend 8.17
Rel. Performance vs Sector -0.74
Analysts 4.16/5
Fair Price Momentum 99.01 USD
Fair Price DCF 81.54 USD

ABT Dividends

Yield 12m 1.98%
Yield on Cost 5y 2.95%
Dividends CAGR 5y 9.77%
Payout Consistency 98.4%

ABT Growth Ratios

Growth 12m -0.43%
Growth Correlation 12m 25%
Growth Correlation 3m -38%
CAGR 5y 8.23%
Sharpe Ratio 12m -0.31
Alpha vs SP500 12m -20.88
Beta vs SP500 5y weekly 0.82
ValueRay RSI 24.42
Volatility GJR Garch 1y 22.29%
Price / SMA 50 -5.68%
Price / SMA 200 1.11%
Current Volume 2519k
Average Volume 20d 5452.9k

External Links for ABT Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of ABT stocks?
As of April 26, 2024, the stock is trading at USD 106.86 with a total of 2,518,991 shares traded.
Over the past week, the price has changed by +1.51%, over one month by -2.38%, over three months by -4.50% and over the past year by -0.86%.
What is the forecast for ABT stock price target?
According to ValueRays Forecast Model, ABT Abbott Laboratories will be worth about 109.6 in April 2025. The stock is currently trading at 106.86. This means that the stock has a potential upside of +2.52%.
Issuer Forecast Upside
Wallstreet Target Price 126.7 18.6
Analysts Target Price 110.7 3.55
ValueRay Target Price 109.6 2.52

Abbott Laboratories: A Comprehensive Overview

The History of Abbott Laboratories

Founded by Dr. Wallace C. Abbott in 1888, Abbott Laboratories started as a small pharmaceutical operation in Chicago. Its inception was marked by the innovative approach of Dr. Abbott, who began by formulating known drugs into tiny, easy-to-use pills. This was a significant departure from traditional practices, setting the stage for a legacy of innovation. Over the decades, Abbott expanded its reach, not just in pharmaceuticals, but also into diagnostics, medical devices, and nutrition, thereby solidifying its place in the healthcare industry.

Core and Side Businesses

Abbott Laboratories operates through four main business segments:

  • Diagnostics: Offers a wide range of diagnostic systems and tests for detection of diseases.
  • Medical Devices: This comprises cardiovascular devices and diabetes care products that help people manage their health effectively.
  • Nutrition: Nutrition segment produces infant formulas, nutritional products for children, and dietetic foods.
  • Branded Generic Pharmaceuticals: Provides a broad line of branded, generic pharmaceuticals, primarily in emerging markets.

Aside from these core segments, Abbott has also ventured into other areas through strategic acquisitions, technology advancements, and research initiatives, which further diversify its operations and strengthen its market position.

Current Market Status

Today, Abbott Laboratories is recognized as a global leader in healthcare, with its products reaching millions across the world. The company's commitment to innovation has powered its growth, with significant investments in research and development. Financially, Abbott has demonstrated robust performance, with steady revenue growth and a strong stock market presence, showcasing its resilience and adaptability in the face of changing market dynamics. As of 2023, Abbott continues to expand its global reach and impact, staying true to its mission of providing cutting-edge, accessible healthcare solutions.